| MORPHOSYS AG O.N. | 105.80 / -0.09% |
| Date/Time | 09/20 / 17:35 |
| Chg. / Chg.(%) | -0.10 / -0.09% |
| Bid | - |
| Ask | - |
| Open | 106.10 |
| Previous Close | 105.90 |
| High | 107.10 |
| Low | 105.00 |
| Volume [EUR] | 13,444,625.50 |
| Volume [Units] | 126,934 |
| Price fixings | 1112 |
| ISIN | DE0006632003 |
| Security | MOR |
| Exchange | Xetra |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 105.400 |  |
|
| Xetra | 105.80 | |
126,934 |
| London Inter.. | 105.70 | |
28,603 |
| Nasdaq Other.. | 116.8000 | |
25,000 |
| Cboe Europe .. | 106.10 | |
17,158 |
| Turquoise | 106.10 | |
6,447 |
| TradeGate | 105.500 | |
5,566 |
| Cboe Europe .. | 106.10 | |
5,447 |
| Frankfurt | 105.6000 | |
408 |
| Stuttgart | 105.600 | |
20 |
| Vienna Globa.. | 106.20 | |
0 |
| Hannover | 105.30 | |
0 |
| Berlin | 106.00 | |
0 |
| München | 105.20 | |
0 |
| Hamburg | 105.30 | |
0 |
| Düsseldorf | 106.00 | |
0 |
| SIX Swiss Ex.. | 102.00 | |
|
| gettex | 105.800 | |
|
| EUREX | Options | ||
News
- Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
04/23/2019 / 22:02 - GlobeNewswire - Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
04/23/2019 / 22:01 - GlobeNewswire - Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106
09/13/2018 / 22:04 - GlobeNewswire - Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106
09/13/2018 / 22:01 - GlobeNewswire - MorphoSys and Galapagos announce U.S. Antitrust Clearance for global license agreement for MOR106 with pharma partner
09/12/2018 / 22:03 - GlobeNewswire
Real-time